Higher VCAM-1 levels were independently associated with increased risk of lymph-node-metastasis (LNM), ≥pT3 disease, and non-organ-confined disease (NOCD (p < 0.001 for each). The gene discussed is VCAM1; the disease is metastatic malignant neoplasm in the lymph nodes.